Frédéric C.
- Country
- France
- Department
- Endocrinology
Research Overview
- Efficacy of Metyrapone in Patients with Primary Bilateral Macronodular Adrenal Hyperplasia and Mild Autonomous Cortisol Secretion: A Randomized Controlled Trial
- Adjuvant mitotane vs. mitotane with cisplatin/etoposide after primary surgical resection of localised adrenocortical carcinoma with high risk of recurrence (ADIUVO-2 Trial): A pragmatic, randomised, low-intervention phase III, clinical trial with an observational arm.
- Phase II Open-Label Study on Safety, Tolerability, Pharmacokinetics, and Efficacy of AG13909 in Adults with Cushing's Disease
Data & Insights
Has run more than one trial at 17 of 78 partner sites.
Specializations
Endocrine Disorders
The investigator specializes in treating complex endocrine system disorders, with particular expertise in Cushing's Disease, a rare condition characterized by excessive cortisol production. Their research encompasses innovative therapeutic approaches for managing hormonal imbalances and their systemic effects.
- Cortisol regulation therapies
- Neuroendocrine disorders
- Pituitary gland dysfunction
Their work includes evaluating novel therapeutic agents targeting hormonal pathways in endocrine disorders.
Oncological Endocrinology
The investigator focuses on treating adrenocortical carcinoma, a rare and aggressive form of endocrine cancer. Their expertise extends to developing comprehensive treatment strategies combining surgical and medical interventions for optimal patient outcomes.
- Endocrine tumor management
- Adjuvant therapy protocols
- Adrenal gland disorders
Their research encompasses both targeted therapies and combination treatment approaches for endocrine system malignancies.
Therapeutic Innovation
The investigator's work involves evaluating novel therapeutic compounds for rare endocrine disorders. Their research includes assessment of drug efficacy, safety profiles, and physiological responses in patients with complex endocrine conditions.
- Novel drug development
- Treatment optimization
- Clinical outcomes assessment
Their approach integrates pharmacological innovation with patient-centered treatment strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.